Tag - AURA

Markets

Analysts start AURA Biosciences at OP, buy

Analysts for SVB Leerink and BTIG initiated coverage of AURA Biosciences (NASDAQ:AURA) with “outperform” and “buy” ratings and price targets of $40 and $38, respectively. The stock closed at $19.82 on Nov. 22. AURA is a...

November 23, 2021

Feature

Verisante to seek FDA approval of Aura skin cancer device

By Len Zehr In addition to ramping up distribution of its Aura non-invasive skin cancer detection device this year, Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) is preparing the process to seek FDA approval of Aura...

June 11, 2013

Tag - AURA

Analysts start AURA Biosciences at OP, buy

Verisante to seek FDA approval of Aura skin cancer device

General

More